Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Efficacy and Safety of Pembrolizumab and Chemotherapy in Newly-Diagnosed, Early Unfavorable or Advanced Classic Hodgkin Lymphoma: The Phase 2 Keynote-C11 Study

Ranjana H. Advani, Abraham Avigdor, Anna Maria Sureda Balari, David Lavie, Stefan Hohaus, Jan M. Zaucha, Vu Minh Hua, Vittorio Ruggero Zilioli, Raimundo Gazitua, Muhit Ozcan, Amos Odeleye-Ajakaye, Nishitha Reddy, Patricia Marinello, Jane N. Winter

Blood (2023) 142 (Supplement 1): 3068.

https://doi.org/10.1182/blood-2023-181171

Published: 2023

Journal Articles

Epidemiology, Clinical Features and Outcomes of Peripheral T-Cell Lymphoma in Latin America

Thais Fischer, Henry Idrobo, Astrid Pavlovsky, Denisse Castro, Brady Beltran, Daniel J Enriquez, Jule F Vasquez, Claudia Roche, Daniel Artiles, Fabiola Valvert, Luis Mario Villela, Juliana Pereira, Carolina Oliver, Jamila Vaz Tavarez, Sergio Augusto B Brasil, Karin Z Cecyn, Nelson Castro, Renata Baptista, Samuel de S Medina, Davimar Miranda Maciel Borducchi, Marcelo Bellesso, Danielle Leao Cordeiro De Farias, Yung Bruno Gonzaga, Fernando Warley, Lorena Fiad, Laura Korin, Patricio Hernan Pereyra, Camila Peña, Maria Alejandra Torres, Carolina Valeria Mahuad, Alana Von Glasenapp, Alfredo Reinaldo Quiroz, Raimundo Gazitua, Cesar Augusto Samanez-Figari, Lautaro Sardu, Juan Pablo Arriola, Sebastian Isnardi, Juan L. Maradei, Raul Hector Gabus, Alicia I. Enrico, Luciana A Guanchiale, Florencia Negri Arangueren, Juan Ignacio García Altuve, Amalia Cerutti, Romina Penalva, Jose Ignacio Garcia Trucco, Florencia Pessolani, Virginia Gilli, Joaquin Diaz, Maria Enriqueta Martinez, Gustavo Jarchum, Gabriela Celia Perinotto, Teresa Barraza, Sergio Ciarlo, Christine Rojas, Rosa Oliday Rios Jiménez, Carmino De Souza, Martina Manni, Eliana C M CM Miranda, Massimo Federico, Bryan Valcarcel, Carlos Chiattone, Luis Enrique Malpica Castillo

Blood (2023) 142 (Supplement 1): 186.

https://doi.org/10.1182/blood-2023-187254

Published: 2023

Journal Articles

Pembrolizumab and Chemotherapy in Newly-Diagnosed, Early Unfavorable or Advanced Stage Classic Hodgkin Lymphoma: The Phase 2 Keynote-C11 Study

Ranjana H. Advani, Abraham Avigdor, Anna Sureda, David Lavie, Stefan Hohaus, Jan M. Zaucha, Vu Minh Hua, Vittorio Ruggero Zilioli, Raimundo Gazitua, Muhit Özcan, Amos Odeleye-Ajakaye, Uzor C. Ogbu, Akash Nahar, Jane N. Winter

Blood (2022) 140 (Supplement 1): 1759–1760.

https://doi.org/10.1182/blood-2022-163787

Published: 2022

Journal Articles

Pegathor Lymphoma, a Phase 2 Study of SAR444245 As a Monotherapy or in Combination with Pembrolizumab for the Treatment of Adults and Adolescents with Relapsed or Refractory B Cell Lymphoma

Alejandro Berkovits, Eduardo Yanez, Christine Rojas, Raimundo Gazitua, Nicolás Cazap, Anna Sureda, Rao Saleem, Robin Meng, Jing Xu, Michael Streit, Valentine Barboux, Sairah Ahmed

Blood (2022) 140 (Supplement 1): 12020–12021.

https://doi.org/10.1182/blood-2022-159980

Published: 2022

Journal Articles

Unequal Outcomes in Transplant Eligible Patients with Multiple Myeloma in Latin America: Differences between Public and Private Centers

Camila Peña, MD, Natalia Paola Schutz, MDMSc, Virginia Bove, MD, Fiorella Villano, MD, Rocío Osorio, MD, Mauricio Chandia, MD, Cecilia Beltran, MD, Javier Schulz, MD, Daniela Cardemil, MD, Carolina Contreras, MD, Carmen Gloria Vergara, MD, Javiera Donoso, MD, Marcela Espinoza, MD, Gabriel La Rocca, MD, Hernán López-Vidal, MD, Pilar León, MD, Christine Rojas, MD, Pablo Soto, MD, Sandra Aranda, MD, Vivianne Torres, MD, Paola Ochoa, MD, Patricio Duarte, MD, Guillermina Remaggi, MD, Sebastian Yantorno, MD, Ariel Corzo, MD, Soledad Zabaljauregui, MD, Claudia Shanley, MD, Sergio Lopresti, MD, Sergio Orlando, MD, Veronica Verri, MD, Luis Darío Quiroga, MD, Carlos García, MD, Vanesa Fernandez, MD, Dorotea Fantl, MD, Jhoanna Ramirez, MD, Alicia Molina, MD, Pilar Papilco, MD, Alex Mite, MD, Ines Reyes, MD, Brener Sabando, MD, Francisca M. Ramirez Aspiazu, MD, Claudia Lucia Sossa, MD, Virginia Abello, MD, Henry Idrobo, MD Professor, Kenny Galvez, MD, Domingo Saavedra, MD, Guillermo Quintero, MD MBA, Raimundo Gazitua, MD, Lina Gaviria, MD, Rigoberto Gomez, MD, Monica Osuna Pérez, MD, Alicia Henao-Uribe, MD, Luz del Carmen Tarín Arzaga, MD, Omar Cantú-Martínez, MD, David Gomez-Almaguer, MD, Yarely Itzayana García-Navarrete, MD, Antonio Cruz-Mora, MD, Yahveth Cantero-Fortiz, MD, Guillermo J. Ruiz-Arguelles, FRCP, MACP, Macarena Roa, MD, Eloisa Riva, MD

Blood (2019) 134 (Supplement_1): 5497.

https://doi.org/10.1182/blood-2019-127555

Published: 2019

NARROW

Efficacy and Safety of Pembrolizumab and Chemotherapy in Newly-Diagnosed, Early Unfavorable or Advanced Classic Hodgkin Lymphoma: The Phase 2 Keynote-C11 Study

Epidemiology, Clinical Features and Outcomes of Peripheral T-Cell Lymphoma in Latin America

Pembrolizumab and Chemotherapy in Newly-Diagnosed, Early Unfavorable or Advanced Stage Classic Hodgkin Lymphoma: The Phase 2 Keynote-C11 Study

Pegathor Lymphoma, a Phase 2 Study of SAR444245 As a Monotherapy or in Combination with Pembrolizumab for the Treatment of Adults and Adolescents with Relapsed or Refractory B Cell Lymphoma

Unequal Outcomes in Transplant Eligible Patients with Multiple Myeloma in Latin America: Differences between Public and Private Centers

Email alerts

ASH Publications

American Society of Hematology

Efficacy and Safety of Pembrolizumab and Chemotherapy in Newly-Diagnosed, Early Unfavorable or Advanced Classic Hodgkin Lymphoma: The Phase 2 Keynote-C11 Study

Epidemiology, Clinical Features and Outcomes of Peripheral T-Cell Lymphoma in Latin America

Pembrolizumab and Chemotherapy in Newly-Diagnosed, Early Unfavorable or Advanced Stage Classic Hodgkin Lymphoma: The Phase 2 Keynote-C11 Study

Pegathor Lymphoma, a Phase 2 Study of SAR444245 As a Monotherapy or in Combination with Pembrolizumab for the Treatment of Adults and Adolescents with Relapsed or Refractory B Cell Lymphoma

Unequal Outcomes in Transplant Eligible Patients with Multiple Myeloma in Latin America: Differences between Public and Private Centers

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only